Home › Funds › DF Tactical Momentum VIT
Fund family: Northern Lights Variable Trust · Filed by Northern Lights Variable Trust (CIK 1352621) · SEC series S000016887
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 516 with, 35 against, 0 abstentions (not counted as with management). Shareholder proposals: 14 FOR, 21 AGAINST, 0 abstained, by the filing’s own vote-source field.
No item-level comparison with other Northern Lights Variable Trust funds is possible: fewer than three other funds of the family voted in 2025-2026.
The same votes as “with management” above, by the sector of the company voted on. 100.0% of this fund’s 551 such votes could be given a sector.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Finance | 128 | 6 | 4.7% |
| Technology | 99 | 6 | 6.1% |
| Industrials | 89 | 5 | 5.6% |
| Health Care | 87 | 6 | 6.9% |
| Telecommunications | 54 | 5 | 9.3% |
| Consumer Discretionary | 30 | 3 | 10.0% |
| Utilities | 19 | 1 | 5.3% |
| Energy | 17 | 2 | 11.8% |
| Basic Materials | 15 | 1 | 6.7% |
| Real Estate | 13 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 382 | 0 |
| Say-on-Pay | 41 | 0 |
| Audit-related | 39 | 0 |
| Corporate Governance | 37 | 17 |
| Compensation | 18 | 0 |
| Capital Structure | 10 | 0 |
| Environment or Climate | 9 | 9 |
| Other Social Issues | 7 | 7 |
| Extraordinary Transactions | 6 | 0 |
| Human Rights or Human Capital/workforce | 1 | 1 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Western Digital Corporation | November 20, 2025 | $4M | 11 | 0 |
| Cardinal Health, Inc. | November 5, 2025 | $2M | 14 | 0 |
| Target Corporation | June 10, 2026 | $2M | 18 | 3 |
| Cboe Global Markets, Inc. | May 14, 2026 | $2M | 15 | 1 |
| Principal Financial Group, Inc. | May 19, 2026 | $2M | 8 | 0 |
| Merck & Co., Inc. | May 26, 2026 | $2M | 18 | 3 |
| Eli Lilly and Company | May 4, 2026 | $2M | 10 | 2 |
| DexCom, Inc. | May 27, 2026 | $2M | 14 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| June 10, 2026 | Target Corporation | Shareholder proposal requesting policy requiring the Board Chair to be an independent director. Shareholder proposal | For | Against |
| June 10, 2026 | Target Corporation | Shareholder proposal requesting a report on presence of pesticides in Target's private label brands. Shareholder proposal | Against | For |
| May 14, 2026 | Cboe Global Markets, Inc. | Stockholder proposal regarding shareholder right to act by written consent. Shareholder proposal | For | Against |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposal | Against | For |
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposal | For | Against |
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to prepare an annual lobbying report. Shareholder proposal | Against | For |
| April 23, 2026 | Johnson & Johnson | Independent Board Chair Shareholder proposal | Against | For |
| February 24, 2026 | Apple Inc. | A shareholder proposal entitled "China Entanglement Audit" Shareholder proposal | Against | For |
| May 27, 2026 | Exxon Mobil Corporation | Independent Chair, a proposal overwhelmingly defeated on 16 separate occasions since 2000 Shareholder proposal | Against | For |
| May 27, 2026 | Exxon Mobil Corporation | Proposal requesting Company to modify its Voluntary Retail Voting Program to provide multiple options not aligned with the Board's recommendations Shareholder proposal | For | Against |
| May 2, 2026 | Cincinnati Financial Corporation | A nonbinding shareholder proposal, if properly presented at the meeting. Shareholder proposal | For | Against |
552 ballot items at 41 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, DF Tactical Momentum VIT voted at 41 shareholder meetings of 40 companies, on 552 ballot items in all. Where management made a recommendation, the fund followed it on 93.6% of the items and voted against it 35 times. Its most frequent area of disagreement was corporate governance (17 of its votes against management). It voted on 35 shareholder proposals.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.